Drug Pricing Debate in Washington Is a Headache for Pharma

A last-ditch effort by Democrats to pass a slimmed-down version of Build Back Better could include measures on drug pricing, putting pressure on the pharma sector.Read More

Tags

Share this post:

JOIN THE HYVE

Gain insights, receive dynamic opportunities directly to your inbox. Sign up now…